Jiangxi Jiangnan New Material Technology
603124
Ningbo Daye Garden Machinery
300879
Shaoyang Victor Hydraulics
301079
4
Baoding Dongli Machinery
301298
5
Fujian Superpipe
300198
US Stock MarketDetailed Quotes
TIL Instil Bio
- 19.8700
- -1.1200-5.34%
Close Mar 19 16:00 ET
129.67MMarket Cap-1.74P/E (TTM)
22.0925High19.3600Low67.35KVolume21.1800Open20.9900Pre Close1.35MTurnover2.52%Turnover RatioLossP/E (Static)6.53MShares92.000052wk High0.77P/B53.05MFloat Cap9.620052wk Low--Dividend TTM2.67MShs Float589.8000Historical High--Div YieldTTM13.02%Amplitude6.0600Historical Low20.0650Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Instil Bio Stock Forum
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
Tuesday, 14th January at 7:00 am
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China
ImmuneOnco announced initial clinical data from the 1L advanced NSCLC trial in China is expected as early as 2H 2025
Instil is target...
keep 👀 $Instil Bio (TIL.US)$
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...
No comment yet